# Acorn Energy, Inc.: financial statements, quarterly

ACFN · Nasdaq · CIK 880984 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acfn.md) · [Financials](/companies/acfn/financials.md) · [Filings](/companies/acfn/filings.md) · [Insiders](/companies/acfn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/acfn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,087](/filings/0001493152-24-043923.md) | [2,250 d](/filings/0001493152-25-009325.md) | [2,132](/filings/0001641172-25-009174.md) | [2,275](/filings/0001641172-25-022519.md) | [3,050](/filings/0001493152-25-020996.md) | [3,529 d](/filings/0001493152-26-008937.md) | [3,098](/filings/0001493152-26-021622.md) | [3,525](/filings/0001493152-26-036270.md) | [2,478](/filings/0001493152-25-020996.md) | [2,377 d](/filings/0001493152-26-008937.md) | [2,227](/filings/0001493152-26-021622.md) | [2,489](/filings/0001493152-26-036270.md) |
| Cost of revenue | $k | [537](/filings/0001493152-24-043923.md) | [602 d](/filings/0001493152-25-009325.md) | [541](/filings/0001641172-25-009174.md) | [610](/filings/0001641172-25-022519.md) | [863](/filings/0001493152-25-020996.md) | [973 d](/filings/0001493152-26-008937.md) | [772](/filings/0001493152-26-021622.md) | [886](/filings/0001493152-26-036270.md) | [533](/filings/0001493152-25-020996.md) | [472 d](/filings/0001493152-26-008937.md) | [442](/filings/0001493152-26-021622.md) | [439](/filings/0001493152-26-036270.md) |
| Gross profit | $k | [1,550](/filings/0001493152-24-043923.md) | [1,648 d](/filings/0001493152-25-009325.md) | [1,591](/filings/0001641172-25-009174.md) | [1,665](/filings/0001641172-25-022519.md) | [2,187](/filings/0001493152-25-020996.md) | [2,556 d](/filings/0001493152-26-008937.md) | [2,326](/filings/0001493152-26-021622.md) | [2,639](/filings/0001493152-26-036270.md) | [1,945](/filings/0001493152-25-020996.md) | [1,905 d](/filings/0001493152-26-008937.md) | [1,785](/filings/0001493152-26-021622.md) | [2,050](/filings/0001493152-26-036270.md) |
| Research and development | $k | [212](/filings/0001493152-24-043923.md) | [261 d](/filings/0001493152-25-009325.md) | [238](/filings/0001641172-25-009174.md) | [226](/filings/0001641172-25-022519.md) | [234](/filings/0001493152-25-020996.md) | [314 d](/filings/0001493152-26-008937.md) | [291](/filings/0001493152-26-021622.md) | [265](/filings/0001493152-26-036270.md) | [267](/filings/0001493152-25-020996.md) | [271 d](/filings/0001493152-26-008937.md) | [255](/filings/0001493152-26-021622.md) | [239](/filings/0001493152-26-036270.md) |
| Selling, general and administrative | $k | [1,330](/filings/0001493152-24-043923.md) | [1,309 d](/filings/0001493152-25-009325.md) | [1,275](/filings/0001641172-25-009174.md) | [1,181](/filings/0001641172-25-022519.md) | [1,197](/filings/0001493152-25-020996.md) | [1,397 d](/filings/0001493152-26-008937.md) | [1,431](/filings/0001493152-26-021622.md) | [1,427](/filings/0001493152-26-036270.md) | [1,519](/filings/0001493152-25-020996.md) | [1,355 d](/filings/0001493152-26-008937.md) | [1,659](/filings/0001493152-26-021622.md) | [1,436](/filings/0001493152-26-036270.md) |
| Operating income | $k | [8.0](/filings/0001493152-24-043923.md) | [78.0 d](/filings/0001493152-25-009325.md) | [78.0](/filings/0001641172-25-009174.md) | [258](/filings/0001641172-25-022519.md) | [756](/filings/0001493152-25-020996.md) | [845 d](/filings/0001493152-26-008937.md) | [604](/filings/0001493152-26-021622.md) | [947](/filings/0001493152-26-036270.md) | [159](/filings/0001493152-25-020996.md) | [279 d](/filings/0001493152-26-008937.md) | [(129)](/filings/0001493152-26-021622.md) | [375](/filings/0001493152-26-036270.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | [25.0](/filings/0001641172-25-009174.md) | [0.0 d](/filings/0001641172-25-022519.md) | [42.0](/filings/0001493152-25-020996.md) | [(4,378) d](/filings/0001493152-26-008937.md) | [154](/filings/0001493152-26-021622.md) | [242](/filings/0001493152-26-036270.md) | [(65.0)](/filings/0001493152-25-020996.md) | [(765) d](/filings/0001493152-26-008937.md) | [(25.0)](/filings/0001493152-26-021622.md) | [105](/filings/0001493152-26-036270.md) |
| Net income | $k | [24.0](/filings/0001493152-24-043923.md) | [84.0 d](/filings/0001493152-25-009325.md) | [65.0](/filings/0001641172-25-009174.md) | [271](/filings/0001641172-25-022519.md) | [725](/filings/0001493152-25-020996.md) | [5,233 d](/filings/0001493152-26-008937.md) | [464](/filings/0001493152-26-021622.md) | [720](/filings/0001493152-26-036270.md) | [252](/filings/0001493152-25-020996.md) | [1,074 d](/filings/0001493152-26-008937.md) | [(77.0)](/filings/0001493152-26-021622.md) | [294](/filings/0001493152-26-036270.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001493152-24-043923.md) | not reported | [0.03](/filings/0001641172-25-009174.md) | [0.11](/filings/0001641172-25-022519.md) | [0.29](/filings/0001493152-25-020996.md) | not reported | [0.19](/filings/0001493152-26-021622.md) | [0.28](/filings/0001493152-26-036270.md) | [0.10](/filings/0001493152-25-020996.md) | not reported | [(0.03)](/filings/0001493152-26-021622.md) | [0.12](/filings/0001493152-26-036270.md) |
| Basic EPS | $ per share | [0.01](/filings/0001493152-24-043923.md) | not reported | [0.03](/filings/0001641172-25-009174.md) | [0.11](/filings/0001641172-25-022519.md) | [0.29](/filings/0001493152-25-020996.md) | not reported | [0.19](/filings/0001493152-26-021622.md) | [0.29](/filings/0001493152-26-036270.md) | [0.10](/filings/0001493152-25-020996.md) | not reported | [(0.03)](/filings/0001493152-26-021622.md) | [0.12](/filings/0001493152-26-036270.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2024-09-30) | period not labelled (2024-11-05) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-05-06) | Q2 FY2025 (2025-06-30) | period not labelled (2025-08-05) | Q3 FY2025 (2025-09-30) | period not labelled (2025-11-04) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.2](/filings/0001493152-24-043923.md) | [2.1](/filings/0001493152-24-043923.md) | [2.3](/filings/0001493152-25-009325.md) | [2.6](/filings/0001641172-25-009174.md) | [2.7](/filings/0001641172-25-009174.md) | [3.3](/filings/0001641172-25-022519.md) | [3.4](/filings/0001641172-25-022519.md) | [4.2](/filings/0001493152-25-020996.md) | [4.4](/filings/0001493152-25-020996.md) | [4.5](/filings/0001493152-26-008937.md) | [4.3](/filings/0001493152-26-021622.md) | [4.5](/filings/0001493152-26-036270.md) |
| Current assets | $m | [4.5](/filings/0001493152-24-043923.md) | not reported | [5.4](/filings/0001493152-26-008937.md) | [6.2](/filings/0001641172-25-009174.md) | not reported | [6.8](/filings/0001641172-25-022519.md) | not reported | [6.7](/filings/0001493152-25-020996.md) | not reported | [7.0](/filings/0001493152-26-036270.md) | [6.6](/filings/0001493152-26-021622.md) | [7.0](/filings/0001493152-26-036270.md) |
| Total assets | $m | [5.4](/filings/0001493152-24-043923.md) | not reported | [10.6](/filings/0001493152-26-008937.md) | [11.1](/filings/0001641172-25-009174.md) | not reported | [12.5](/filings/0001641172-25-022519.md) | not reported | [12.4](/filings/0001493152-25-020996.md) | not reported | [13.3](/filings/0001493152-26-036270.md) | [13.1](/filings/0001493152-26-021622.md) | [13.4](/filings/0001493152-26-036270.md) |
| Current liabilities | $m | [4.3](/filings/0001493152-24-043923.md) | not reported | [4.3](/filings/0001493152-26-008937.md) | [4.4](/filings/0001641172-25-009174.md) | not reported | [4.1](/filings/0001641172-25-022519.md) | not reported | [3.9](/filings/0001493152-25-020996.md) | not reported | [3.8](/filings/0001493152-26-036270.md) | [3.5](/filings/0001493152-26-021622.md) | [3.3](/filings/0001493152-26-036270.md) |
| Total liabilities | $m | [5.1](/filings/0001493152-24-043923.md) | not reported | [5.0](/filings/0001493152-26-008937.md) | [5.0](/filings/0001641172-25-009174.md) | not reported | [5.6](/filings/0001641172-25-022519.md) | not reported | [5.2](/filings/0001493152-25-020996.md) | not reported | [5.0](/filings/0001493152-26-036270.md) | [4.7](/filings/0001493152-26-021622.md) | [4.5](/filings/0001493152-26-036270.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [0.3](/filings/0001493152-24-043923.md) | not reported | [5.5](/filings/0001493152-26-008937.md) | [6.1](/filings/0001641172-25-009174.md) | not reported | [6.9](/filings/0001641172-25-022519.md) | not reported | [7.2](/filings/0001493152-25-020996.md) | not reported | [8.3](/filings/0001493152-26-036270.md) | [8.4](/filings/0001493152-26-021622.md) | [8.8](/filings/0001493152-26-036270.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [211 d](/filings/0001493152-24-043923.md) | [(294) d](/filings/0001493152-25-009325.md) | [(43.0)](/filings/0001641172-25-009174.md) | [84.0 d](/filings/0001641172-25-022519.md) | [698 d](/filings/0001493152-25-020996.md) | [166 d](/filings/0001493152-26-008937.md) | [271](/filings/0001493152-26-021622.md) | [629 d](/filings/0001493152-26-036270.md) | [895 d](/filings/0001493152-25-020996.md) | [295 d](/filings/0001493152-26-008937.md) | [53.0](/filings/0001493152-26-021622.md) | [224 d](/filings/0001493152-26-036270.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,481](/filings/0001493152-23-040001.md) | [2,483](/filings/0001493152-24-018334.md) | [2,487](/filings/0001493152-24-030676.md) | [2,532](/filings/0001493152-24-043923.md) | [2,494](/filings/0001641172-25-009174.md) | [2,507](/filings/0001641172-25-022519.md) | [2,511](/filings/0001493152-25-020996.md) | [2,498](/filings/0001493152-26-021622.md) | [2,534](/filings/0001493152-26-036270.md) | [2,554](/filings/0001493152-25-020996.md) | [2,506](/filings/0001493152-26-021622.md) | [2,540](/filings/0001493152-26-036270.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,509,618 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001493152-26-036270.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.